Article Text

Download PDFPDF

Short report
Molecular diversity of Treponema pallidum subspecies pallidum isolates in Amsterdam, the Netherlands
  1. Helene C A Zondag1,
  2. Akke R Cornelissen1,
  3. Alje P van Dam1,2,
  4. Sylvia M Bruisten1,3
  1. 1 Department of Infectious Diseases, Public Health Laboratory, Public Health Service of Amsterdam, Amsterdam, The Netherlands
  2. 2 Department of Medical Microbiology, Amsterdam University Medical Centre, Amsterdam, The Netherlands
  3. 3 Amsterdam Infection & Immunity, Amsterdam University Medical Centre, Amsterdam, The Netherlands
  1. Correspondence to Helene C A Zondag, Infectious Diseases, Public Health Laboratory, Public Health Service of Amsterdam, Nieuwe Achtergracht 100, 1018 WT, Amsterdam, The Netherlands; h.zondag{at}amsterdamumc.nl

Abstract

Objectives The prevalence of syphilis, caused by the spirochete Treponema pallidum subsp. pallidum (TPA), remains high despite the availability of effective antibiotics. In the Netherlands, most syphilis cases are found among men who have sex with men (MSM). We studied the distribution of TPA strain types by molecular characterisation and related this to available characteristics. In addition, resistance to macrolides was assessed.

Methods TPA DNA was extracted from 136 genital ulcer swab or skin lesions samples deriving from 135 patients diagnosed with syphilis in 2016 and 2017 at the Public Health Service in Amsterdam, the Netherlands. Molecular typing was done according to the enhanced CDC method (E-CDC), in which three genetic regions of the arp, tpr and tp0548 genes are analysed by gel electrophoresis of the arp and tpr regions and by sequence analysis for the tp0548 region. Part of the 23S rDNA locus was sequenced to determine the presence of macrolide resistance-associated mutations.

Results Full E-CDC strain types could be determined for 99/136 (73%) DNA samples, which tested positive in a diagnostic PCR targeting the polA gene. Types differed within one patient of whom two samples were available. No association was found between the demographic and clinical characteristics and the TPA types. The most prevalent type was 14d/g, found in 23 of the 99 (23%) fully typed samples. Part of the 23S rDNA locus was successfully sequenced for 93/136 (68%) samples and 83 (88%) contained the A2058G mutation. No A2059G mutation was found.

Conclusions A broad strain distribution was found. Few subtypes were clonally expanded, and most other subtypes were rare. Detection of the most prevalent strain type, 14d/g, is in concordance with other TPA typing studies. The high prevalence of genetic macrolide resistance indicates that azithromycin is not an alternative treatment option.

  • treponema pallidum
  • molecular typing
  • macrolide resistance
  • syphilis
https://creativecommons.org/licenses/by/4.0/

This is an open access article distributed in accordance with the Creative Commons Attribution 4.0 Unported (CC BY 4.0) license, which permits others to copy, redistribute, remix, transform and build upon this work for any purpose, provided the original work is properly cited, a link to the licence is given, and indication of whether changes were made. See: https://creativecommons.org/licenses/by/4.0/.

Statistics from Altmetric.com

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Footnotes

  • Handling editor Nicola Low

  • Contributors Conceptualisation: SMB. Analysis: HCAZ and ARC. Writing: HCAZ, AvD and SMB. Supervision: SMB.

  • Funding This study was funded by Public Health Laboratory, GGD Amsterdam, Amsterdam, The Netherlands (R&D 7572.2172).

  • Competing interests None declared.

  • Patient consent for publication Not required.

  • Ethics approval According to the Dutch Medical Research Act Involving Human Subjects, no additional ethical approval was required for this study (W19_113#19.146).

  • Provenance and peer review Not commissioned; externally peer reviewed.